Precision Biosciences Inc (DTIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 86,076 | 99,370 | 110,823 | 44,870 | 62,242 |
| Marketable Securities | 1,473 | 1,814 | 4,762 | 0 | 0 |
| Receivables | N/A | 4,000 | N/A | 4 | N/A |
| Other current assets | 5 | 6 | 45 | 974 | 567 |
| TOTAL | $91,549 | $108,693 | $118,740 | $51,705 | $70,259 |
| Non-Current Assets | |||||
| PPE Net | 964 | 1,183 | 1,425 | 2,026 | 2,356 |
| Investments And Advances | 744 | 744 | 744 | 744 | 744 |
| Intangibles | 1,093 | 1,127 | 1,166 | 985 | 605 |
| Other Non-Current Assets | 31,570 | 32,144 | 32,341 | 38,050 | 34,964 |
| TOTAL | $34,371 | $35,198 | $35,676 | $41,805 | $38,669 |
| Total Assets | $125,920 | $143,891 | $154,416 | $93,510 | $108,928 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 828 | 944 | 296 | 1,340 | 1,121 |
| Accrued Expenses | 4,116 | 4,396 | 6,461 | 4,454 | 3,441 |
| Other current liabilities | 588 | 858 | 649 | 611 | 721 |
| TOTAL | $7,140 | $7,755 | $8,913 | $14,996 | $13,568 |
| Non-Current Liabilities | |||||
| Long Term Debt | 22,421 | 22,419 | 22,404 | 22,374 | 22,354 |
| Deferred Revenues | N/A | N/A | N/A | 6,248 | 5,989 |
| Other Non-Current Liabilities | 51,066 | 37,616 | 30,851 | 19,549 | 18,727 |
| TOTAL | $73,487 | $60,035 | $53,255 | $61,880 | $61,306 |
| Total Liabilities | $80,627 | $67,790 | $62,168 | $76,876 | $74,874 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,602 | 25,802 | 24,727 | 13,257 | 11,787 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -579,281 | -546,629 | -528,188 | -548,321 | -526,549 |
| Other shareholders' equity | 48 | 48 | 48 | 48 | 48 |
| TOTAL | $45,293 | $76,101 | $92,248 | $16,634 | $34,054 |
| Total Liabilities And Equity | $125,920 | $143,891 | $154,416 | $93,510 | $108,928 |